ACOR
Acorda Therapeutics, Inc.
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
34 hedge funds and large institutions have $5.42M invested in Acorda Therapeutics, Inc. in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 4 closing their positions.
Holders
34
Holders Change
–
Holders Change %
0%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
10
Closed
4
Calls
$63K
Puts
$6K
Net Calls
+$57K
Net Calls Change
+$81K
Top Buyers
1 |
1
Jane Street
New York
|
$22K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$4K |
3 |
3
Citigroup
New York
|
$3K |
4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$1K |
5 |
5
Northern Trust
Chicago,
Illinois
|
$43K |